Improving cervical cancer prevention for HIV-positive women in Mexico and Puerto Rico
CAMPO Administrative and Coordinating Core
This research is all about helping women with HIV in Mexico and Puerto Rico by testing new ways to find and treat cervical cancer, including better screening methods, the use of probiotics, and a new HPV vaccine.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11177200 on NIH RePORTER |
What this research studies
This research focuses on preventing cervical cancer among HIV-positive women in Mexico and Puerto Rico through three clinical studies. The first study will test new screening methods for detecting high-grade cervical lesions in 4,000 women. The second study will explore the effects of probiotics on the microbiota and their potential to help reverse anal and cervical lesions in 600 participants. The third study will assess the safety and effectiveness of a new therapeutic HPV vaccine in treating cervical and anal lesions in 300 individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are HIV-positive women and men living in Mexico and Puerto Rico.
Not a fit: Patients who are not HIV-positive or those who do not reside in Mexico or Puerto Rico may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of cervical cancer in HIV-positive women.
How similar studies have performed: Previous research has shown promising results in similar approaches to cervical cancer prevention among HIV-positive populations.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Palefsky, Joel Michael — University of California, San Francisco
- Study coordinator: Palefsky, Joel Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.